Keywords: ASD, >6 year-old, <11 year-old, Biomarkers of Treatment Outcomes in Neurodevelopmental Disorders
What is being studied?
The purpose of this study is to examine the combined effects of medication and a behavioral intervention on language development in children with autism. To measure this, we are using both eye tracking and EEG to study face processing and language learning prior to and after intervention. Data from this study can inform an empirically based approach to intervention for children with an ASD and low language ability.
Who can participate?
If you have a child between 6 and 11 years of age with an ASD and low language ability you may be eligible to participate in this study.
What does the study involve?
Participants will receive either Aripiprazole or a placebo, along with an engagement-based language intervention. Participation also requires some parent questionnaires, interviews, and psychological testing.
Whom should I contact to get involved?
If interested in participating in this study, contact Jenny Cowen at (310) 825-6170 or by email at